[1]
R. Sitepu, P. Ascobat, F. Ekasari, and I. Instiaty, “FIXED-DOSE COMBINATION VERSUS SEPARATE ANTITUBERCULOSIS FORMULATIONS IN PULMONARY TUBERCULOSIS PATIENTS: EVALUATION OF EFFECTIVENESS AND SAFETY”, Int J App Pharm, vol. 10, no. 1, pp. 208–210, Dec. 2018.